Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin‐based therapies
Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin‐based therapies
复制标题
接受肠促胰岛素治疗的患者内分泌和外分泌胰腺组织的组织学变化
作者:
Ueberberg S;Jütte H;Schmidt WE;Nauck MA;Montanya E;Tannapfel A;Meier JJ
AimsIncretin‐based therapies have been associated with an increased risk of pancreatitis. Recently, various histological abnormalities have been reported in human pancreatic tissue from brain‐dead organ donors who had been exposed to incretin‐based drugs. In the present study we examined pancreatic tissue collected at surgery.MethodsHuman pancreatic tissue from 7 type 2‐diabetic patients treated with incretin‐based drugs (type 2‐I), 6 diabetic patients without incretin treatment (type 2‐NI), 11 patients without diabetes (no diabetes group) and 9 brain‐dead organ donors (BDOD group) was examined.ResultsFractional beta‐cell area was reduced in the type 2‐NI group compared to the group without diabetes (P< .05), but there was no difference compared to the type 2‐I patients. Alpha‐cell area (P= .30), beta‐cell replication (P= .17) and alpha‐cell replication (P= .91) were not different. There were also no differences in acinar cell (P= .13) and duct cell replication (P= .099). Insulin‐positive duct cells were more frequent in the type 2‐I and the BDOD groups (P= .034). No co‐expression of insulin and glucagon was detected. Pancreatic intraepithelial neoplasia (PanIN) lesions were very rare, all low‐grade (PanIN 1a and 1b) and tended to occur more frequently in the type 2‐I group (P= .084).ConclusionsThe present results did not reveal marked histological abnormalities in the pancreas of incretin‐treated patients with type 2 diabetes. Low numbers of specimens available and a large inter‐individual variability of the findings warrant caution regarding the interpretation of histological data concerning drug effects on the human pancreas.
登录
查看更多内容
影响因子:
3.8
作者:
Raschi, E.;Piccinni, C.;De Ponti, F.
通讯作者:
De Ponti, F.
DOI:
10.1056/nejmoa1305889
发表时间:
2013-10-03
期刊:
The New England journal of medicine
影响因子:
--
作者:
White, William B;Cannon, Christopher P;Zannad, Faiez
通讯作者:
Zannad, Faiez
影响因子:
8.2
作者:
Butler, P. C.;Matveyenko, A. V.;Dry, S.;Bhushan, A.;Elashoff, R.
通讯作者:
Elashoff, R.
影响因子:
7.7
作者:
Gier B;Matveyenko AV;Kirakossian D;Dawson D;Dry SM;Butler PC
通讯作者:
Butler PC
影响因子:
5.8
作者:
J. Meier;Christina U. Köhler;Bacel Alkhatib;C. Sergi;T. Junker;H. Klein;W. Schmidt;H. Fritsch
通讯作者:
H. Fritsch